Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

The Immune Response Corporation and Bayer to codevelop hemophilia A gene therapy

July 19, 1996

AlphaNine SD cleared by FDA

July 19, 1996

C85: TxB2 production/phosphoinositide breakdown inhibitor

July 19, 1996

Terumo discloses fibrinogen (gpIIb/IIIa) antagonists

July 19, 1996

Platelet aggregation inhibitors from Meiji Seika

July 19, 1996

Fibrinogen antagonists from DuPont Merck

July 19, 1996

Fibrinogen antagonists from Merck & Co.

July 19, 1996

BASF reveals thrombin inhibitor as thrombosis/arterial reocclusion therapy

July 19, 1996

NovoSeven hits U.K. market

July 12, 1996

TxA2 antagonists/TxA2 synthase inhibitors from Fujisawa

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 11, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...